Approval · Notice of Compliance 28667 · 2022
EMAVERT: Notice of Compliance 28667
Issued July 29, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28667
- Date
- July 29, 2022
- Company
- Dechra Regulatory BvBladel, --, Netherlands
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- CERENIA (Zoetis Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EMAVERT | 02529564 | Marketed |
Medicinal ingredients
- MAROPITANT 10 MG per ML